Gemcitabine and docetaxel versus doxorubicin as first-line treatment in previously untreated advanced unresectable or metastatic soft-tissue sarcomas (GeDDiS): a randomised controlled phase 3 trial

Beatrice Seddon, Sandra J. Strauss, Jeremy Whelan, +16

The Lancet Oncology

Adjuvant bevacizumab in patients with melanoma at high risk of recurrence (AVAST-M): preplanned interim results from a multicentre, open-label, randomised controlled phase 3 study

Pippa Corrie, Andrea Marshall, Janet Dunn, +17

The Lancet Oncology

Patterns of Expression of DNA Repair Genes and Relapse From Melanoma

Rosalyn Jewell, Caroline Conway, Angana Mitra, +16

Clinical Cancer Research

Ipilimumab in the real world

Saif Ahmad, Wendi Qian, Sarah Ellis, +26

Melanoma Research

Baseline Neutrophil–Lymphocyte and Platelet–Lymphocyte Ratios as Biomarkers of Survival in Cutaneous Melanoma: A Multicenter Cohort Study

Ryckie G. Wade, A Robinson, Michelle Lo, +5

Annals of Surgical Oncology

Ipilimumab-induced colitis: experience from a tertiary referral center

Anthony O’Connor, Maria Marples, C Mulatero, +2

Therapeutic Advances in Gastroenterology

Cutaneous lupus associated with pembrolizumab therapy for advanced melanoma: a report of three cases

Elizabeth Blakeway, Noha Elshimy, Andrew Muinonen‐Martin, +3

Melanoma Research

Checkpoint Blockade ImmunotherapyImmunologyPathologyPembrolizumab TherapyDermatology +17

Complications of bone metastases from malignant melanoma

Jamal Zekri, Maria Marples, Dominic Taylor, +3

Journal of bone oncology

Adjuvant therapy with pegylated interferon-alfa2b vs observation in stage II B/C patients with ulcerated primary: Results of the European Organisation for Research and Treatment of Cancer 18081 randomised trial

Alexander M.M. Eggermont, Piotr Rutkowski, Caroline Dutriaux, +19

European Journal of Cancer

European OrganisationGastrointestinal OncologyMedicineImmunologyClinical Trials +8

Small bowel villous atrophy due to immune-checkpoint inhibitors: report of two cases and literature review

Annalisa Schiepatti, Andrea C. Premoli, Stiliano Maimaris, +8

Drugs in Context

ImmunologyGastroenterologyPathologySmall Bowel InvolvementImmunotherapy +15